3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Sell
27
AKTX Quote, Financials, Valuation and Earnings
Last price:
$1.27
Seasonality move
:
5.09%
Day range:
$1.26 - $1.38
52-week range:
$0.85 - $4.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.64x
Volume:
17.5K
Avg. volume:
26.5K
1-year change:
-22.93%
Market cap:
$36.4M
Revenue:
--
EPS (TTM):
-$2.75
Earnings Data
Next earnings date for AKTX
May 16
2025
Most recent earnings per share
-$0.14
Missed by $0.14
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AKTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | -- | -$0.14 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/19/2024 | Q2 | -- | -- | -$0.80 | -- | -- |
| 05/16/2024 | Q1 | -- | -- | -$0.83 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.88 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.57 | -- | -- |
| 09/27/2023 | Q2 | -- | -- | -$0.79 | -$1.00 | $0.21 |
| 05/16/2023 | Q1 | -- | -- | $0.26 | -$1.20 | $1.46 |
| 12/31/2022 | Q4 | -- | -- | -- | -$1.40 | -- |
| 09/30/2022 | Q3 | -- | -- | -- | -$0.80 | -- |
| 09/27/2022 | Q2 | -- | -- | -$1.91 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.93 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$2.49 | -- | -- |
| 12/03/2021 | Q3 | -- | -- | -$0.62 | -- | -- |
| 09/22/2021 | Q2 | -- | -- | -$2.26 | -- | -- |
| 06/29/2021 | Q1 | -- | -- | -$3.04 | -- | -- |
| 03/31/2021 | Q4 | -- | -- | -$13.84 | -- | -- |
| 12/11/2020 | Q3 | -- | -- | $0.54 | -- | -- |
| 09/01/2020 | Q2 | -- | -- | -$4.96 | -- | -- |
| 05/29/2020 | Q1 | -- | -- | -$2.98 | -- | -- |
| 03/16/2020 | Q4 | -- | -- | -$7.30 | -- | -- |
| 11/04/2019 | Q3 | -- | -- | -$2.60 | -- | -- |
| 08/29/2019 | Q2 | -- | -- | -$5.12 | -- | -- |
| 04/23/2019 | Q1 | -- | -- | -$3.22 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$4.44 | -- | -- |
| 11/15/2018 | Q3 | -- | -- | -$4.70 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$20.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$1.75 | -- | -- |
| 03/21/2018 | Q4 | -- | -- | -$20.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$20.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.54 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$20.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$20.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.71 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$20.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$5.07 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $40.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$120.00 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$4.00 | -- | -- |
Akari Therapeutics PLC Earnings Questions
-
How Much did Akari Therapeutics PLC Generate in Revenue Last Quarter?
Akari Therapeutics PLC reported -- worth of top line sales in its most recent quarter.
-
Did Akari Therapeutics PLC Beat Earnings Last Quarter?
Akari Therapeutics PLC announced earnings per share of -$0.14 which represents a miss of analyst forecast a -- per share.
-
Is Akari Therapeutics PLC Profitable?
Akari Therapeutics PLC reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Akari Therapeutics PLC EPS Next Year?
Akari Therapeutics PLC's earnings are forecast to decrease from -- per share to -- per share next year representing a decrease of -29.64%.
-
When is Akari Therapeutics PLC's Earnings Date?
Akari Therapeutics PLC's next earnings date is May 16, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
